+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop



Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop



Hepatology 46(2): 566-581



Biliary atresia is the most common cause of end-stage liver disease in the infant and is the leading pediatric indication for liver transplantation in the United States. Earlier diagnosis (<30-45 days of life) is associated with improved outcomes following the Kasai portoenterostomy and longer survival with the native liver. However, establishing this diagnosis is problematic because of its rarity, the much more common indirect hyperbilirubinemia that occurs in the newborn period, and the schedule for routine infant health care visits in the United States. The pathogenesis of biliary atresia appears to involve immune-mediated fibro-obliteration of the extrahepatic and intrahepatic biliary tree in most patients and defective morphogenesis of the biliary system in the remainder. The determinants of the outcome of portoenterostomy include the age at surgery, the center's experience, the presence of associated congenital anomalies, and the postoperative occurrence of cholangitis. A number of screening strategies in infants have been studied. The most promising are early measurements of serum conjugated bilirubin and a stool color card given to new parents that alerts them and their primary care provider to alcholic stools. This report summarizes a National Institutes of Health workshop held on September 12 and 13, 2006, in Bethesda, MD, that addressed the issues of outcomes, screening, and pathogenesis of biliary atresia.

(PDF emailed within 0-6 h: $19.90)

Accession: 055670292

Download citation: RISBibTeXText

PMID: 17661405

DOI: 10.1002/hep.21790


Related references

From The National Institutes of Health. Summary of the National Institutes of Health Research Workshop on the Epidemiology of the Acquired Immunodeficiency Syndrome (AIDS). Journal of Infectious Diseases 150(2): 295-303, 1984

National Institutes of Health workshop summary. Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in individuals with asthma. Journal of Allergy and Clinical Immunology 76(2 Pt 1): 145-147, 1985

From the National Institute of Allergy and Infectious Diseases. Summary of the National Institutes of Health workshop on group B streptococcal infection. Journal of Infectious Diseases 148(1): 163-166, 1983

Measuring hot flashes: summary of a National Institutes of Health workshop. Mayo Clinic Proceedings 79(6): 777-781, 2004

Biliary atresia and liver transplantation: the National Institutes of Health point of view. Pediatrics 74(1): 159-160, 1984

Anhydramnios in the Setting of Renal Malformations: The National Institutes of Health Workshop Summary. Obstetrics and Gynecology 131(6): 1069-1079, 2018

From the National Institutes of Health. Summary of a workshop on cytomegalovirus infections during organ transplantation. Journal of Infectious Diseases 139(6): 728-734, 1979

Pigment gallstone disease: Summary of the National Institutes of Health--international workshop. Hepatology 2(6): 879-884, 1982

Summary of workshop on drinking water fluoride influence on hip fracture on bone health. (National Institutes of Health, 10 April, 1991). Osteoporosis International 2(3): 109-117, 1992

Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. Journal of Urology 140(1): 203-206, 1988

Summary of the National Institutes of Health workshop on primary human immunodeficiency virus type 1 infection. Aids Research and Human Retroviruses 9(9): 913-924, 1993

Slow viruses and inborn metabolic errors. Summary of a workshop sponsored by the National Institutes of Health. Archives of Neurology 21(6): 645-648, 1969

Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013. Human Gene Therapy 25(6): 488-497, 2015

Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012. Human Gene Therapy 24(4): 355-362, 2014

Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop. Controlled Clinical Trials 22(5): 485-502, 2001